Difference between revisions of "Part:BBa K1933002"

Revision as of 18:37, 18 October 2016

anti-Norovirus GII.4 scFv

This part codes for anti-Norovirus GII.4 scFv (single-chain variable fragment) which derives from human 12A2 antibody. This scFv is suggested to prevent binding of human norovirus to Hist-Blood Group Antigens[1].
This coding sequence was fused to INPNC-His (BBa_K1933001) or BclA-His (BBa_K1933000) in our project.
For more information, please visit [http://2016.igem.org/Team:Kyoto our wiki]

Sequence and Features

Assembly Compatibility:

10
COMPATIBLE WITH RFC[10]
12
COMPATIBLE WITH RFC[12]
21
INCOMPATIBLE WITH RFC[21]
Illegal XhoI site found at 387
23
COMPATIBLE WITH RFC[23]
25
COMPATIBLE WITH RFC[25]
1000
COMPATIBLE WITH RFC[1000]

Usage and Biology

NoV binding to Histo-blood group antigen (HBGA), expressed in red blood cells and duodenum cells, is suggested to be an important part of NoV invasion. Also, NoV binding to 12A2 antibody in its HBGA binding site has been demonstrated previously. [2] The scFv coded in our part derives from antibody 12A2, so it also sterically blocks the binding of NoV to HBGA in theory, which might neutralize NoV using the same mechanism.

We used this part for construction of ☆BBa_K1933200 and BBa_K1933201.

Characterization

Please see ☆BBa_K1933200 and BBa_K1933201 for full characterization.

Reference

[1]Higo‐Moriguchi, Kyoko, et al. "Isolation of cross‐reactive human monoclonal antibodies that prevent binding of human noroviruses to histo‐blood group antigens." Journal of medical virology, 86.4, (2014): 558-567.

[2]Shanker, Sreejesh, et al. "Structural basis for norovirus neutralization by an HBGA blocking human IgA antibody." Proceedings of the National Academy of Sciences (2016): 201609990.

@@ Line 14: / Line 14: @@
 ==Usage and Biology==
-NoV binding to Histo-blood group antigen (HBGA), expressed in red blood cells and duodenum cells, is suggested to be an important part of NoV invasion. Also, NoV binding to 12A2 antibody in its HBGA binding site has been demonstrated previously. [2] The scFv coded in our part derives from antibody 12A2, so it also sterically block the binding of NoV to HBGA in theory, which might neutralize NoV using the same mechanism.
+NoV binding to Histo-blood group antigen (HBGA), expressed in red blood cells and duodenum cells, is suggested to be an important part of NoV invasion. Also, NoV binding to 12A2 antibody in its HBGA binding site has been demonstrated previously. [2] The scFv coded in our part derives from antibody 12A2, so it also sterically blocks the binding of NoV to HBGA in theory, which might neutralize NoV using the same mechanism.
 <br><br>We used this part for construction of [https://parts.igem.org/Part:BBa_K1933200 ☆BBa_K1933200] and [https://parts.igem.org/Part:BBa_K1933201 BBa_K1933201].